Amlitelimab (KY1005) is a monoclonal antibody targeting OX40 ligand (OX40L), inhibiting KLH-driven immune responses, used in the study of atopic dermatitis.
Purity:
>95%
Target:
Immunology/Inflammation related
* VAT and and shipping costs not included. Errors and price changes excepted